Literature DB >> 30773075

Thrombophilia, risk factors and prevention.

Elena Campello1, Luca Spiezia1, Angelo Adamo1, Paolo Simioni1.   

Abstract

INTRODUCTION: Fifty-three years after the first description of an inherited prothrombotic condition (antithrombin deficiency), our knowledge on hereditary and acquired causes of hypercoagulability that can predispose carriers to venous thromboembolism (VTE) has greatly improved. Areas covered: Main causes of hereditary thrombophilia are summarized alongside new prothrombotic mutations recently discovered. The main causes of acquired thrombophilia, and namely, antiphospholipid antibody syndrome and hyperhomocysteinemia, are also discussed together with other common acquired prothrombotic states characterized by an increase of procoagulant factors and/or a decrease of natural anticoagulants. Finally, suggestions for thromboprophylaxis in carriers of hereditary thrombophilia according to current guidelines/evidence are made for the most challenging high-risk situations (i.e. surgery, pregnancy, contraception, cancer, economy class syndrome) as well as for the prevention of post-thrombotic syndrome. Expert opinion: A carrier of inherited thrombophilia should be evaluated in the framework of other (genetic and/or acquired) coexisting risk factors for first or recurrent VTE when assessing the need and duration of prevention (primary prophylaxis). Prevention strategies should be tailored to each patient and every situational risk factor. The knowledge of the carriership status of severe thrombophilia in the proband can be important to provide asymptomatic relatives with adequate counseling on thrombophilia screening or primary thromboprophylaxis.

Entities:  

Keywords:  Deep vein thrombosis; inherited and acquired thrombophilia; pregnancy; pulmonary embolism; thromboprophylaxis; venous thromboembolism

Year:  2019        PMID: 30773075     DOI: 10.1080/17474086.2019.1583555

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  13 in total

Review 1.  Thrombotic risk in antiphospholipidic syndrome: From hypothesis to current evidence (Review).

Authors:  Claudia Mihaela Gavriș; Laurențiu Dănuț Nedelcu; Alina Mihaela Pascu
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

Review 2.  Approach to Thrombophilia in Pregnancy-A Narrative Review.

Authors:  Miruna Samfireag; Cristina Potre; Ovidiu Potre; Raluca Tudor; Teodora Hoinoiu; Andrei Anghel
Journal:  Medicina (Kaunas)       Date:  2022-05-23       Impact factor: 2.948

3.  Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.

Authors:  Elena Campello; Luca Spiezia; Chiara Simion; Daniela Tormene; Giuseppe Camporese; Fabio Dalla Valle; Anna Poretto; Cristiana Bulato; Sabrina Gavasso; Claudia Maria Radu; Paolo Simioni
Journal:  J Am Heart Assoc       Date:  2020-11-23       Impact factor: 5.501

4.  Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis.

Authors:  Cheuk-Kwan Sun; Kuo-Chuan Hung; Carlos Andrés Gómez; I-Ting Tsai; Yang-Pei Chang; Ming-Chung Lin; I-Yin Hung; Ying-Jen Chang; Li-Kai Wang; Yao-Tsung Lin
Journal:  Sci Rep       Date:  2021-08-06       Impact factor: 4.379

5.  Relationship between Hypercoagulable State and Circulating Tumor Cells in Peripheral Blood, Pathological Characteristics, and Prognosis of Lung Cancer Patients.

Authors:  Yanhua Jiao; Liling Guo; Linqian Wu; Tongshan Hu
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-21       Impact factor: 2.629

Review 6.  Multi-factorial Mechanism Behind COVID-19 Related Thrombosis.

Authors:  Elshazali Widaa Ali; Ibrahim Khedir Ibrahim
Journal:  Med Arch       Date:  2022-02

7.  Unraveling a borderline antithrombin deficiency case with quantitative mass spectrometry.

Authors:  Mirjam Kruijt; Liselotte M van der Pol; Jeroen Eikenboom; Harjo J Verburg; Christa M Cobbaert; L Renee Ruhaak
Journal:  J Thromb Haemost       Date:  2021-10-26       Impact factor: 16.036

8.  Trends of Ordering Hypercoagulability Work-Up at an Academic Medical Center.

Authors:  Marjan Alidoost; Gabriella A Conte; Varsha Gupta; Swapnil Patel; Ishan Patel; Mohammed Shariff; Shreya Gor; Michael J Levitt; Arif Asif; Mohammad A Hossain
Journal:  J Blood Med       Date:  2021-05-28

9.  Subacute combined degeneration of the spinal cord concurrent with acute pulmonary embolism: a case report.

Authors:  Xinyuan Pang; Yulei Hao; Lushun Ma; Lu Liu; Jiachun Feng
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

10.  [Chinese guidelines for diagnosis, prevention and treatment of thrombophilia (2021)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.